Examiner Noah Kamen
Grant ratio: 81.3% (96th percentile in Art Unit 3783 among examiners with at least 20 applications). Average office actions per grant: 1.30. Most common rejection type: §103.
Appears inactive
Last office action in data: September 2014
Examiner record
Save this analysis
Download this examiner report.
Log in / Sign Up to exportPeer comparisons
| Group | Examiners | Average grant ratio | Average office actions / grant |
|---|---|---|---|
| Art Unit | 81 | 45.9% | 1.98 |
| Group | 297 | 41.7% | 1.90 |
| Tech Center | 2,671 | 48.4% | 2.01 |
| USPTO | 16,475 | 52.7% | 1.98 |
Office actions per application
| Office actions | Applications | Share of applications |
|---|---|---|
| No OA observed | 0 | 0.0% |
| 1 OA | 412 | 76.9% |
| 2 OAs | 100 | 18.7% |
| 3 OAs | 22 | 4.1% |
| 4 OAs | 1 | 0.2% |
| 5+ OAs | 1 | 0.2% |
Each application is counted once. “5+” includes all higher counts.
Grant history
Recent ratios may be lower while applications remain pending.
Yearly counts
| Year | Applications | Grants | Grant rate |
|---|---|---|---|
| 2007 | 1 | 0 | 0.0% |
| 2008 | 79 | 64 | 81.0% |
| 2009 | 99 | 84 | 84.8% |
| 2010 | 81 | 60 | 74.1% |
| 2011 | 105 | 85 | 81.0% |
| 2012 | 76 | 63 | 82.9% |
| 2013 | 54 | 46 | 85.2% |
| 2014 | 41 | 34 | 82.9% |
Rejections by office-action stage
| Office-action stage | Actions observed | §101 | §102 | §103 | §112 |
|---|---|---|---|---|---|
| Action 1 | 536 | 0.9% | 27.4% | 42.0% | 17.4% |
| Action 2 | 124 | 0.8% | 25.8% | 54.0% | 9.7% |
| Action 3 | 24 | 0.0% | 8.3% | 66.7% | 20.8% |
| Action 4 | 2 | 0.0% | 0.0% | 100.0% | 0.0% |
| Action 5 | 1 | 0.0% | 0.0% | 100.0% | 0.0% |
Section 101 rejections
Last 3 years: 2023-08-28–2026-08-28. All years includes every dated office action in the data.
By year
0.0%
0.0%
1.7%
0.0%
0.7%
2.1%
0.0%
2014: Alice
2.2%
Each bar is the percentage of office actions with a §101 rejection.
PTAB appeals
No PTAB decisions could be matched to this examiner.
Older and transferred applications may not have a reliable examiner match. Data through Aug. 27, 2026.